Please use this identifier to cite or link to this item:
http://repository.li.mahidol.ac.th/dspace/handle/123456789/51299| Title: | Is Oral Ribavirin for the Treatment of Respiratory Syncytial Virus in High-risk Hematopoietic Stem Cell Transplant Recipients Really Safe? |
| Authors: | Shilpa R. Jain Pakpoom Phoompoung Shahid Husain University Health Network University of Toronto Faculty of Medicine, Siriraj Hospital, Mahidol University |
| Keywords: | Medicine |
| Issue Date: | 27-Nov-2019 |
| Citation: | Clinical Infectious Diseases. Vol.69, No.12 (2019), 2234-2235 |
| URI: | http://repository.li.mahidol.ac.th/dspace/handle/123456789/51299 |
| metadata.dc.identifier.url: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075805521&origin=inward |
| ISSN: | 15376591 10584838 |
| Appears in Collections: | Scopus 2019 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.